Document xjD6axe6kvv1Rxxo8oeZXdQp1

To: Clegg, Patsy M SCC-DCS/22 <patsy.clegg@shell.com> From: Snyder, Phil J SCC-DCS/2 </O=SHE LUOU=MSXSCC/CN=RE CI PI ENTS/CN=PS193987> Cc: Bcc: Received Date: 2007-03-03 17:56:04 GMT Subject: FW: API letters Phil Snyder Global Manager Downstream Product Stewardship Shell Chemical LP One Shell Plaza, P.O. Box 2463, Houston, TX 77252-2463 Tel: +1 713241 7826 Fax: +1 713 - 241 2494 Other Tel: +1 832-721-6493 Email: Phil.Snyder@Shell.com Internet: http://www.shell.com/chemicals -----Original Message----- From: Clegg, Patsy M SCC-DCS/22 Sent: Friday, March 02,20079:25 PM To: Snyder, Phil J SCC-DCS/2; Williams, Elizabeth J SCAI-DCS/22 Subject: API letters Phil; I sent the Shell letter to Jennifer Galvin. When she read it, she called Mark Fitzsimmons. They both strongly felt that the words in the Shell letter would not accomplish what we wanted. They felt that it exposed the relationship between the consortium and API; gave API stronger authority; would not be supported by the other consortium members; and used too many words that provided targets. We had a lengthy discussion where they shared their reactions and we challenged each other. In the end, Jennifer elected to send a much shorter letter. They also felt that the consortium would be better served if our letters were aligned. With this as background, I called you and John. Not getting an answer, I called Elizabeth. We discussed both the Shell letter and Jennifer's letter. In the end, we recommend that I send a much shorter version of the letter. We recognize and appreciate all the work that went into crafting the language. However, on further reflection and having heard the reaction of both CP and Mark - which I view as a good barometer of what would be the consortium reaction - I feel that it is better to keep it short. I am requesting your support to send the attached letter. I recognize that we have missed the API deadline, but both Elizabeth and I feel that it was more important to get your input prior to sending. I have a fax machine at my home, so can send the letter out tomorrow. You may reach me at my home, 281-358-1506 or on my cell, 832-419-3931. For reference, the original version: Patsy Clegg Product Steward Shell Chemical LP One Shell Plaza, 91 0 Louisiana, Houston, TX 77002-4916 SHELL-MCCLURG-062144 Tel: +1 713241 2521 Fax: 3325 Email: patsy.clegg@shell.com Internet: http://www.shell.com/chemicals Attachments: Jennifer letter.ZIP Shanghai Irons Letter March 2 2007 - content.ZIP Shanghai Irons Letter March 2 2007 - short versiot.ZIP SHELL-MCCLURG-062145 March 2, 2007 Via Electronic and U.S. Mail Richard Irons, PhD, DABT Principal Investigator, Shanghai Health Study University of Colorado Health Sciences Center 4200 East 9th Avenue, C238 Denver, CO 80262 VIA FAX (303) 315-7223 American Petroleum Institute Attention: Harry Ng VIA FAX (202) 682-8033 Re: Supplemental Funding for Shanghai Health Study Gentlemen: On behalf of the Oversight Committee of the Benzene Health Research Consortium (BHRC), I am withdrawing the letter dated February 23, 2007. It has been brought to my attention that the letter did not expressly address the continuing role of American Petroleum Institute (API) as the administrator and contracting entity for the Study. The BHRC has no authority to make any commitment on behalf of API. We remain anxious to continue work on the Study and look forward to making progress in this area. In that regard, I understand API will be in contact with the appropriate parties. Sincerely yours, Patsy Clegg Chair, Oversight Committee Shanghai Health Study An equal opportunity employer SHELL-MCCLURG-062146 cc: Ralph Altiere - (303) 315-6281 FAX Charlotte Klaus - (303) 315-6281 FAX David Ross - (303) 315-0274 FAX Dan Wilkerson - (303) 315-4446 FAX SHELL-MCCLURG-062147 March 2, 2007 Via Electronic and U.S. Mail Richard Irons, PhD, DABT Principal Investigator, Shanghai Health Study University of Colorado Health Sciences Center 4200 East 9th Avenue, C238 Denver, CO 80262 VIA FAX (303) 315-7223 American Petroleum Institute Attention: Harry Ng VIA FAX (202) 682-8033 Re: Supplemental Funding for Shanghai Health Study Gentlemen: On behalf of the Benzene Health Research Consortium ("BHRC"), I am withdrawing the letter dated February 22, 2007. It has been brought to my attention that the letter could be misleading as it did not acknowledge the continuing role of the American Petroleum Institute (API) as the administrator and contracting entity for the Study. We continue to look forward to progressing this important study. In that regard, the Oversight Committee is working with API to initiate the appropriate communication early this week. My apologies for any confusion this may cause. Sincerely, Patsy Clegg Chair, Technical Committee Shanghai Health Study An equal opportunity employer SHELL-MCCLURG-062148